Excipients

The term "Excipients" refers to pharmacologically inactive substances intentionally included in therapeutic or diagnostic products to facilitate manufacturing, enhance stability, improve delivery, or aid patient acceptability³, ⁴, ⁵, ⁶. While there is a significant global market for pharmaceutical excipients, with a projected value reaching over $14 billion by 2033, the term "Excipients" itself does not fall under a broader financial category such as behavioral finance, portfolio theory, or corporate finance.¹, ² Instead, it is a scientific and industrial term specific to the pharmaceutical and healthcare sectors, representing a component within those industries rather than a financial concept or instrument. Therefore, this term is outside the scope of a financial encyclopedia focused on investment and economic principles.